Statement Of Income And Retained Earnings

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7256194

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
JPY
5,331,000,000 JPY
2,000,000 JPY
3,188,000,000 JPY
6,349,000,000 JPY
300,000,000 JPY
6,652,000,000 JPY
-1,321,000,000 JPY
7,647,000,000 JPY
-125,000,000 JPY
-1,216,000,000 JPY
2,499,000,000 JPY
6,500,000,000 JPY
7,717,000,000 JPY
195,000,000 JPY
Non-operating income
Non-operating income
398,000,000 JPY
12,000,000 JPY
6,000,000 JPY
414,000,000 JPY
Non-operating expenses
Non-operating expenses
622,000,000 JPY
9,000,000 JPY
38,000,000 JPY
392,000,000 JPY
Ordinary profit (loss)
5,107,000,000 JPY
3,191,000,000 JPY
2,467,000,000 JPY
6,522,000,000 JPY
Extraordinary income
Extraordinary income
1,384,000,000 JPY
3,340,000,000 JPY
Extraordinary losses
Extraordinary losses
300,000,000 JPY
JPY
Profit (loss) before income taxes
6,192,000,000 JPY
3,191,000,000 JPY
2,467,000,000 JPY
9,862,000,000 JPY
Income taxes - current
750,000,000 JPY
29,000,000 JPY
3,000,000 JPY
3,514,000,000 JPY
Income taxes - deferred
341,000,000 JPY
-1,000,000 JPY
-2,000,000 JPY
-1,197,000,000 JPY
Profit (loss)
3,163,000,000 JPY
5,101,000,000 JPY
3,163,000,000 JPY
3,163,000,000 JPY
3,163,000,000 JPY
2,466,000,000 JPY
2,466,000,000 JPY
2,466,000,000 JPY
7,545,000,000 JPY
2,466,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.